|
Volumn 23, Issue 11, 2013, Pages 3438-3442
|
Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, Part I: Transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
Osteoarthritis(OA)pain; Phosphodiesterase 2 (PDE2)inhibition; Structure based drug design
|
Indexed keywords
PHOSPHODIESTERASE II INHIBITOR;
PHOSPHODIESTERASE INHIBITOR;
PHOSPHODIESTERASE IV INHIBITOR;
UNCLASSIFIED DRUG;
ALKYLATION;
ARTICLE;
CRYSTAL STRUCTURE;
CYCLIZATION;
DRUG BINDING;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
DRUG SELECTIVITY;
ENZYME ACTIVE SITE;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HYDROGEN BOND;
IC 50;
MITSUNOBU REACTION;
OSTEOARTHRITIS;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
AZIRINES;
BINDING SITES;
CATALYTIC DOMAIN;
CRYSTALLOGRAPHY, X-RAY;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 2;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4;
DIHYDROPYRIDINES;
DISEASE MODELS, ANIMAL;
DRUG EVALUATION, PRECLINICAL;
OSTEOARTHRITIS;
PHOSPHODIESTERASE 4 INHIBITORS;
PHOSPHODIESTERASE INHIBITORS;
PROTEIN BINDING;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84877583170
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2013.03.072 Document Type: Article |
Times cited : (17)
|
References (19)
|